Gambro Posiclear
Subsystem, Water Purification. 510(k) K061782, from Gambro Services, Inc. (Minneapolis, MN). Product code FIP, class 2.
As of Nov 19, 2026, K061782 is an FDA 510(k) held by Gambro Services, Inc., substantially equivalent on Jan 4, 2007 after 192 days, with no recalls tied to it in FDA's recall database.
- Review time: 192 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Gambro Posiclear filter is intended to remove bacteria, endotoxin, and particulate matter from water used for hemodialysis. It is intended for use in dialysis water treatment systems as a final stage of filtration after RO or DI treatment to help control bacteria and endotoxin levels in purified water distribution systems.
- RenaPure Endotoxin Retentive FilterK231410 · Evoqua Water Technologies, LLC · Jul 19, 2023
- AquaC UNO HK250471 · Fresenius Medical Care Renal Therapies Group, LLC · Nov 14, 2025
- DIASAFEplusUS (F00013010)K251851 · Fresenius Medical Care Renal Therapies Group, LLC · Oct 9, 2025
- AquaAK252181 · Fresenius Medical Care North America · Sep 9, 2025
- UPT Series Medical RO Water Treatment SystemK250514 · Specialty Water Technologies, Inc. · Mar 17, 2025
- AquaBplus; AquaB LITEK232953 · Fresenius Medical Care Renal Therapies Group, LLC · Jun 13, 2024
- AQUAbase nXK223479 · B.Braun Medical, Inc. · Aug 16, 2023
- RenaPure Endotoxin Retentive FilterK231410 · Evoqua Water Technologies, LLC · Jul 19, 2023
- AmeriWater MediQA Reverse Osmosis System (MSP3HF)K223656 · AmeriWater, LLC · Feb 13, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 26, 2006
- Review panel
- Gastroenterology, Urology
- Regulation
- 21 CFR 876.5665
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files